Adverse events following measles, mumps, rubella and varicella virus vaccine live (PROQUAD<sup>®</sup>) reported to the vaccine adverse event reporting system (VAERS), 2015-2025. [PDF]
Liang G, Liu Q, Song Y.
europepmc +1 more source
Immunity to six vaccine pathogens in HIV positive and HIV negative children in Equatorial Guinea. [PDF]
Rodriguez-Galet A +8 more
europepmc +1 more source
Viral correlates of protection and the multifarious interactions of B and T cells. [PDF]
Meissner HC +3 more
europepmc +1 more source
Promoting Vaccination in the Post-COVID-19 Era. [PDF]
Tsimtsiou Z.
europepmc +1 more source
Trend dynamics of mumps prevalence among children aged 1-9 years in Changzhou, 2005-2023: a joinpoint regression and age-period-cohort analysis. [PDF]
Wu D +10 more
europepmc +1 more source
Evaluation and optimization of mumps-containing vaccination strategies: a study based on an individual-based stochastic model. [PDF]
Wang Y +7 more
europepmc +1 more source
Comparative Immunogenicity and Safety of Measles-Mumps-Rubella Vaccine When Administered Using Needle Free Injection System to That with Conventional Needle-Syringe in India: A Randomized, Parallel Group Study. [PDF]
Ratta BS, Naik A, Mutha S.
europepmc +1 more source
Epidemiological characteristics of major respiratory infectious diseases in Baiyin, China, from 2014 to 2023: a descriptive epidemiological study. [PDF]
Zhan Z +10 more
europepmc +1 more source
Delayed or Absent First Dose of Measles, Mumps, and Rubella Vaccination.
Masters NB +5 more
europepmc +1 more source
Measles Outbreak Associated with an Infectious Traveler - Colorado, May-June 2025. [PDF]
Metz AR +14 more
europepmc +1 more source

